Inpatient Use of Personal Continuous Glucose Monitor (CGM) to Improve Diabetes Mellitus Control

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

June 14, 2026

Study Completion Date

June 14, 2026

Conditions
Diabetes Mellitus
Interventions
DEVICE

Real time CGM data monitoring

CGM data will be monitored in real time during daytime in the hospital. Alerts about high and low glucose levels will be communicated to patient's nurse and treating providers.

DEVICE

Insulin dose adjustment based on glucometer and CGM glucose data trends

Insulin dose will be modulate based on glucometer values and previous day glucose trends as recorded on CGM.

DEVICE

Share CGM data on admission and on discharge from the hospital

Record 14 days' worth of CGM data prior to admission and all CGM data recorded during the hospitalization at the time of discharge from the hospital

Trial Locations (1)

32224

RECRUITING

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER